Abstract
BackgroundStevia (Stevia rebaudiana) is an important medicinal plant that yields diterpenoid steviol glycosides (SGs). SGs are currently used in the preparation of medicines, food products and neutraceuticals because of its sweetening property (zero calories and about 300 times sweeter than sugar). Recently, some progress has been made in understanding the biosynthesis of SGs in Stevia, but little is known about the molecular mechanisms underlying this process. Additionally, the genomics of Stevia, a non-model species, remains uncharacterized. The recent advent of RNA-Seq, a next generation sequencing technology, provides an opportunity to expand the identification of Stevia genes through in-depth transcript profiling.ResultsWe present a comprehensive landscape of the transcriptome profiles of three genotypes of Stevia with divergent SG compositions characterized using RNA-seq. 191,590,282 high-quality reads were generated and then assembled into 171,837 transcripts with an average sequence length of 969 base pairs. A total of 80,160 unigenes were annotated, and 14,211 of the unique sequences were assigned to specific metabolic pathways by the Kyoto Encyclopedia of Genes and Genomes. Gene sequences of all enzymes known to be involved in SG synthesis were examined. A total of 143 UDP-glucosyltransferase (UGT) unigenes were identified, some of which might be involved in SG biosynthesis. The expression patterns of eight of these genes were further confirmed by RT-QPCR.ConclusionRNA-seq analysis identified candidate genes encoding enzymes responsible for the biosynthesis of SGs in Stevia, a non-model plant without a reference genome. The transcriptome data from this study yielded new insights into the process of SG accumulation in Stevia. Our results demonstrate that RNA-Seq can be successfully used for gene identification and transcript profiling in a non-model species.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2164-15-571) contains supplementary material, which is available to authorized users.
Highlights
Stevia (Stevia rebaudiana) is an important medicinal plant that yields diterpenoid steviol glycosides (SGs)
The leaves of three Stevia genotypes (SR-1, SR-2 and SR-3) have dramatically different amounts of ST and RA To select different genotypes of Stevia for comprehensive characterization of genes associated with SG biosynthesis, we used HPLC to analyze the ST and RA contents in the leaves from three Stevia genotypes (SR-1, SR-2 and SR-3)
RNA-sequencing and de novo assembly of three genotypes of Stevia To comprehensively survey the genes associated with SG formation and accumulation, we performed RNA-seq for SR-1, SR-2 and SR-3
Summary
Stevia (Stevia rebaudiana) is an important medicinal plant that yields diterpenoid steviol glycosides (SGs). SGs are non-caloric and non-cariogenic sweeteners with functional and sensory properties superior to many other high-potency sweeteners [3,4] Because of their sweetening property (zero calories and about 300 times sweeter than sugar), SGs have been used widely in the preparation of medicines, beverages and neutraceuticals [5]. SGs. The SG produced by Stevia is a mixture of at least eight different types, including ST (stevioside), RA-RF (rebaudiosides A-F), rubusoside and dulcoside A, a new diterpene glycoside recently isolated from Stevia [8]. Some progress has been made in understanding the biosynthetic pathway of SGs, including the identification of 17 steps catalyzed by different enzymes. Several genes have been demonstrated to be involved in the first seven steps, including
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
